{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:24:04Z","timestamp":1788445444257,"version":"build-2803163510"},"reference-count":123,"publisher":"Informa UK Limited","issue":"13","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gansu Provincial Science and Technology Plan"},{"name":"Gansu Provincial Science and Technology Plan Project for the Natural Science"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2025,11,10]]},"DOI":"10.1080\/10428194.2025.2549519","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:49:37Z","timestamp":1757486977000},"page":"2397-2412","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["The discussion on the differences in immune microenvironment between low-risk and high-risk myelodysplastic syndromes and acute myeloid leukemia"],"prefix":"10.1080","volume":"66","author":[{"given":"Yinglong","family":"Wang","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Hematology Department, The First People\u2019s Hospital of Longnan City","place":["Longnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxue","family":"Zheng","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[{"name":"The Second Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Lanzhou University","place":["Lanzhou, China"]},{"name":"The Second Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College of Lanzhou University","place":["Lanzhou, China"]},{"name":"The Second Hospital of Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.55"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54290-2"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-844696"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01784"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0332"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014472"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.08.012"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030580"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67580"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753425920961157"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14825"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023166"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0909-x"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-844639"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36193-w"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.264"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00518-x"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017007856"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106180"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00464"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2018.08.004"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-02108-3"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2010.08.002"},{"key":"e_1_3_7_26_1","first-page":"201","article-title":"IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia","volume":"683","author":"Chenjiao Y","year":"2013","unstructured":"Chenjiao Y, Zili F, Haibin C, et\u00a0al. IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia. Pharmazie. 2013;683:201\u2013206.","journal-title":"Pharmazie"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00536-x"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406207231183330"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00155"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1050-2"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1062208"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-844670"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.04.002"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15496"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02357"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-713099"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017012369"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.14578"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5VMA1116-454R"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130155"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102900"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0310-y"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09204-4"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2020.12.046"},{"key":"e_1_3_7_45_1","article-title":"Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS","volume":"2187","author":"Trowbridge JJ","year":"2021","unstructured":"JJ Trowbridge, DT Starczynowski. Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS. J Exp Med. 2021;2187, e20201544.","journal-title":"J Exp Med"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01328-x"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4047"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01794"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.12.013"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.10.010"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000713"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400844"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H"},{"key":"e_1_3_7_54_1","article-title":"Endoplasmic reticulum stress promotes the expression of TNF-\u03b1 in THP-1 cells by mechanisms involving ROS\/CHOP\/HIF-1\u03b1 and MAPK\/NF-\u03baB pathways","volume":"2420","author":"Akhter N","year":"2023","unstructured":"Akhter N, Wilson A, Arefanian H, et\u00a0al. Endoplasmic reticulum stress promotes the expression of TNF-\u03b1 in THP-1 cells by mechanisms involving ROS\/CHOP\/HIF-1\u03b1 and MAPK\/NF-\u03baB pathways. Int J Mol Sci. 2023;2420, 15186.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_7_55_1","first-page":"1993","article-title":"Identification of DJ-1\/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis","volume":"11510","year":"2010","unstructured":"AM, Marcondes X, Li TA, et\u00a0al. Identification of DJ-1\/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis. Blood. 2010;11510:1993\u20132002.","journal-title":"Blood"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.637725"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.10.2949"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908892"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.273292"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022236"},{"key":"e_1_3_7_61_1","author":"\u738b\u8dc3\u98de \u9648\u8446\u56fd, \u90d1\u745e","year":"2024","unstructured":"\u738b\u8dc3\u98de \u9648\u8446\u56fd, \u90d1\u745e, et\u00a0al. PD-1\/PD-L1\u5728MDS\u539f\u59cb\u7ec6\u80de\u3001T\u7ec6\u80de\u4e9a\u7fa4\u548cTreg\u7ec6\u80de\u4e2d\u7684\u8868\u8fbe\u53ca\u610f\u4e49. 2024; \u4e2d\u56fd\u5b9e\u9a8c\u8840\u6db2\u5b66\u6742\u5fd7. 3204, 1152\u20131159.","journal-title":"PD-1\/PD-L1\u5728MDS\u539f\u59cb\u7ec6\u80de\u3001T\u7ec6\u80de\u4e9a\u7fa4\u548cTreg\u7ec6\u80de\u4e2d\u7684\u8868\u8fbe\u53ca\u610f\u4e49"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000942"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26282-z"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz0463"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0623-5"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-275446"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.87"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112059"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-730614"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004794"},{"key":"e_1_3_7_72_1","article-title":"Inherited predispositions to myeloid neoplasms: pathogenesis and clinical implications","year":"2024","unstructured":"YC, Liu MK, Eldomery JL, et\u00a0al. Inherited predispositions to myeloid neoplasms: pathogenesis and clinical implications. Annu Rev Pathol. 2024, 20:87\u2013114.","journal-title":"Annu Rev Pathol"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192"},{"key":"e_1_3_7_74_1","volume-title":"Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis","year":"2024","unstructured":"EL, Boertjes S, Massaar A, et\u00a0al. Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis. Blood Adv. 2024, 9:1344\u20131355."},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0314-5"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030320"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013156"},{"key":"e_1_3_7_78_1","first-page":"2386","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"37825","year":"2018","unstructured":"CD, DiNardo EM, Stein S, et\u00a0al. Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML. N Engl J Med. 2018;37825:2386\u20132398.","journal-title":"N Engl J Med"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00263-4"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00665-y"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.950134"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12665"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104181"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.09.001"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152716"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2015.02.025"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584626"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.531491"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12345"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14079-4"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.11.005"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2108"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.018"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11142249"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2016.10.010"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-399683"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0598"},{"key":"e_1_3_7_99_1","first-page":"2391","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"12720","year":"2016","unstructured":"DA, Arber A, Orazi R, et\u00a0al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;12720:2391\u20132405.","journal-title":"Blood"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00908-z"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633537"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.343"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.2217\/ijh-2021-0002"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006158"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216767"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI129317"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3761"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.06.001"},{"key":"e_1_3_7_109_1","first-page":"307","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"5587709","year":"2018","unstructured":"JA, Fraietta CL, Nobles MA, et\u00a0al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature. 2018;5587709:307\u2013312.","journal-title":"Nature"},{"key":"e_1_3_7_110_1","first-page":"2208","article-title":"B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers","volume":"121","year":"2021","unstructured":"VS, Mahajan H, Mattoo N, et\u00a0al. B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers. Nat Commun. 2021;121:2208.","journal-title":"Nat Commun"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26984"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26989"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16628"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021010958"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.336"},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-096297"},{"key":"e_1_3_7_117_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-303669"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0267-9"},{"key":"e_1_3_7_119_1","first-page":"391","article-title":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia","volume":"81","year":"2023","unstructured":"ZW, Huang XN, Zhang L, et\u00a0al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 2023;81:391.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_7_120_1","first-page":"e","article-title":"Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes","volume":"992","year":"2024","unstructured":"AM, Brunner J, Esteve K, et\u00a0al. Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes. Am J Hematol. 2024;992: e 32\u2013e36.","journal-title":"Am J Hematol"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0229"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03454-y"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/life11121318"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013338"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2549519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:17:15Z","timestamp":1764836235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2549519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":123,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,11,10]]}},"alternative-id":["10.1080\/10428194.2025.2549519"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2549519","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}